Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Balance Targeted Exercises for Individuals With MS [NA]
Clinical trial update on a completed study evaluating balance-targeted exercises for individuals with multiple sclerosis. The trial was cond…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex) [NA]
A completed clinical trial evaluated the effectiveness of Levidex, a digital health application, in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Relıabılıty and valıdıty of the supıne-to-stand Test wıth Multiple Sclerosis
A completed clinical trial evaluating the reliability and validity of the supine-to-stand test in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Telehealth Pain Self-Management for Employed Adults [NA]
This report notes the completion of a trial evaluating telehealth pain self-management for employed adults with chronic pain and related neu…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 [Phase 1]
First-in-human Phase 1 trial in healthy adults to evaluate safety, tolerability, and pharmacokinetics of LPX-TI641; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy [Phase 3]
A Phase 3 safety study evaluating immune responses to vaccines in relapsing forms of multiple sclerosis in participants receiving ozanimod v…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating natalizumab for preventing postpartum relapses in multiple sclerosis has completed. Results were posted on 2025-01-…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension) [Phase 4]
This update reports an extension of the MAGNIFY MS trial for Mavenclad in multiple sclerosis, with Phase 4 results posted in January 2025.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis. [Phase 4]
Phase 4 trial evaluating the efficacy and response to ozanimod in multiple sclerosis has been terminated, per the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Stem Cells in Rapidly Evolving Active Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update for a stem cell therapy in rapidly evolving active multiple sclerosis. The Phase 1/Phase 2 study has completed and res…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Pilot Study for the Evaluation of the More Stamina in Persons With Multiple Sclerosis
A completed pilot trial evaluating a treatment called More Stamina for improving stamina in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating anakinra for chronically inflamed white matter lesions in multiple sclerosis has completed, and result…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Exercise Booster Sessions in People With Multiple Sclerosis [NA]
This clinical trial update summarizes a completed study evaluating the effect of exercise booster sessions in people with multiple sclerosis…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Functional Electrical Stimulation Cycling for Managing Mobility Disability in People with Multiple Sclerosis [NA]
The trial evaluating Functional Electrical Stimulation Cycling for mobility disability in people with multiple sclerosis has completed. The …
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: The Effect of Hybrid Telerehabilitation-Based Structured Exercise Programs in Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating hybrid telerehabilitation-based structured exercise programs for people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: HFS (High-Fiber Supplement) in MS (Multiple Sclerosis) [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating a High-Fiber Supplement in individuals with Multiple Sclerosis, with results posted on 2024-12-17.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice
Real-world study evaluating the effectiveness, persistence, tolerability, and safety of ofatumumab in multiple sclerosis patients treated in…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS) [Phase 3]
Phase 3 NOR-MS trial evaluating oral cladribine in combination with rituximab for relapsing multiple sclerosis has completed. The study inve…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: The Effect of Yoga on Sleep Quality, Fatigue and Physical Activity Level of Multiple Sclerosis [NA]
A completed clinical trial evaluated the effect of yoga on sleep quality, fatigue, and physical activity in people with multiple sclerosis. …
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Tele-Exercise and Multiple Sclerosis [NA]
Results have been posted for a completed clinical trial evaluating tele-exercise for individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial [Phase 1]
Phase 1 trial of a dendritic cell-based vaccine for multiple sclerosis has completed, reporting negative results in this first-in-human stud…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Comparative Effectiveness Study Telerehab Versus Conventional [NA]
A comparative effectiveness trial evaluated telerehabilitation versus conventional rehabilitation in people with multiple sclerosis; the stu…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis [NA]
A completed clinical trial evaluating an intervention to reduce perceived cognitive impairment in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Effects of Upper Extremity-Focused Neuromuscular Training in People With Multiple Sclerosis [NA]
Clinical trial update on upper-extremity neuromuscular training for people with multiple sclerosis. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Cubii for Exercise in People With MS [NA]
This clinical trial update reports that the Cubii seated exercise device was studied in people with multiple sclerosis. Results have been po…